 |
|
| Cruise News | ||||||
|
||||||
Home > Cruise News > NCL Releases Swine Flu Travel Advisory |
||||||
April 28, 2009 |
||||||
NCL Releases Swine Flu Travel Advisory |
||||||
Norwegian Cruise Line (NCL) has responded to the CDC's recommendation against non-essential travel to Mexico. The following is the statement released by NCL (at 7:00 pm EST on April 28, 2009), explaining what they are going to be doing regarding their ships that typically visit Mexican ports of call: The health and well-being of our guests and crew is of the utmost importance to Norwegian Cruise Line. Accordingly, the company is closely monitoring the health advisories regarding the current Swine Influenza (Swine Flu) situation.As a precautionary measure due to the recent travel advisory relating to Mexico, the company is cancelling Norwegian Pearl's final two calls in Mexico on its current repositioning cruise. The stops were scheduled for tomorrow, Wednesday, April 29 and Friday, May 1, 2009. Apart from this sailing, Norwegian Cruise Line's scheduled deployment does not include any other ports of call in Mexico until the end of September 2009. Norwegian Cruise Line has stringent protocols for cleaning and sanitation on all of its vessels to prevent the spread of infectious diseases.  In addition, the company is taking proactive precautionary measures to protect its valued guests, including, but not limited to, fleet-wide guest screening via a health questionnaire prior to embarkation and on-board education regarding Swine Flu symptoms and preventative actions. As a result, the company does not anticipate that its guests' cruise experience will be impacted.Furthermore, Norwegian Cruise Line's on-board medical centers are stocking an appropriate amount of the anti-viral medication used to treat the illness, in the unlikely event the need for its use becomes necessary. Any further updates will be posted to ncl.com. For information on swine influenza, visit the CDC's web site at www.cdc.gov |
||||||
|
Custom Search
© 2012, CruisEvolution LLC. All Rights Reserved.